Suppr超能文献

HPV 检测用于宫颈癌初筛后细胞学判读的变化:英国试点的观察性研究。

Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot.

机构信息

Cancer Prevention Group, School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.

Severn Pathology, Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom.

出版信息

Cancer Cytopathol. 2022 Jul;130(7):531-541. doi: 10.1002/cncy.22572. Epub 2022 Apr 4.

Abstract

BACKGROUND

Overcalling of abnormalities has been a concern for using cytology triage after positive high-risk human papillomavirus (HPV) tests in cervical screening.

METHODS

The authors studied the detection of cytological and histological abnormalities at age 24 to 64 years, using data from the English HPV pilot. The pilot compared routine implementation of primary cervical screening based on cytology (N = 931,539), where HPV test results were not available before cytology reporting, with that based on HPV testing (N = 403,269), where cytology was only required after positive HPV tests.

RESULTS

Revealed HPV positivity was associated with a higher direct referral to colposcopy after any abnormality (adjusted odds ratio [OR ], 1.16; 95% confidence interval [CI], 1.14-1.18). Laboratories with higher direct referral referred fewer persistently HPV-positive women after early recall. The detection of high-grade cervical intraepithelial neoplasia (CIN2+) after direct referral increased with an OR of 1.17 (95% CI, 1.13-1.20) for informed versus uninformed cytology. Generally, the positive predictive value (PPV) of colposcopy for CIN2+ remained comparable under both conditions of interpreting cytology. In women 50 to 64 years old with high-grade dyskaryosis, however, the PPV increased from 71% to 83% after revealing HPV positivity (OR , 2.05; 95% CI, 1.43-2.93).

CONCLUSIONS

Quality-controlled cervical screening programs can avoid inappropriate overgrading of HPV-positive cytology.

摘要

背景

在宫颈癌筛查中,高危型人乳头瘤病毒(HPV)检测阳性后进行细胞学分流时,过度诊断异常一直是人们关注的问题。

方法

作者利用英国 HPV 试点研究的数据,研究了 24 至 64 岁时细胞学和组织学异常的检出情况。该试点研究比较了基于细胞学的常规初级宫颈筛查(N=931539)和基于 HPV 检测的筛查(N=403269)的效果,后者仅在 HPV 检测阳性后才进行细胞学检查。

结果

HPV 阳性与任何异常后直接转诊行阴道镜检查的可能性增加相关(校正比值比 [OR],1.16;95%置信区间 [CI],1.14-1.18)。直接转诊率较高的实验室在早期召回后,HPV 持续阳性的女性人数较少。直接转诊后高级别宫颈上皮内瘤变(CIN2+)的检出率随着知情细胞学检查的 OR 增加而增加(1.17;95%CI,1.13-1.20)。一般来说,两种情况下,阴道镜检查对 CIN2+的阳性预测值(PPV)均保持相当。然而,在 50 至 64 岁的高级别细胞学异常女性中,HPV 阳性后 PPV 从 71%增加至 83%(OR,2.05;95%CI,1.43-2.93)。

结论

质量控制的宫颈筛查计划可以避免对 HPV 阳性细胞学检查的不适当过度分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a310/9542289/f2bdeb99044e/CNCY-130-531-g003.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验